ᐈ Abselion benchtop tech emerges victorious from UK’s dragon’s den

📰 Abselion benchtop tech emerges victorious from UK’s dragon’s den. Abselion, a benchtop small molecule reaction screening technology, has secured £550k funding on the BBC show. The technology can be used in various industries including pharmaceuticals, agrochemistry, and materials science. The funding will help in scaling up the technology for industrial use. 👨‍🔬💡

📢 Abselion benchtop tech emerges victorious from UK’s dragon’s den

Introduction:

This article discusses the success of Abselion, a Swedish company specializing in benchtop battery technology, on the UK TV show “Dragon’s Den”. The company was able to secure funding from the show’s investors, allowing them to further develop their innovative technology.

Main points:

Abselion is a Swedish company that has developed a new type of benchtop battery technology.
The company recently appeared on the UK TV show “Dragon’s Den” to pitch their product to a panel of investors.
Despite facing tough questions and scrutiny, Abselion was able to secure funding from the show’s investors, enabling them to continue developing their technology.
The company’s benchtop battery technology offers several advantages over traditional batteries, including increased energy density and faster charging times.
Abselion plans to use the funding to further refine their product and bring it to market.

Conclusion:

The success of Abselion on “Dragon’s Den” is a significant milestone for the company and their benchtop battery technology. With the funding secured from the show’s investors, Abselion can continue their development efforts and potentially bring their innovative product to market. The success of this Swedish company highlights the potential for advancements in battery technology and the importance of support from investors and funding programs in the biotechnology industry.